Comparison of Effectiveness and Safety of Sirolimus-Eluting Stents Versus Bare-Metal Stents in Patients With Diabetes Mellitus (from the Italian Multicenter Randomized DESSERT Study)

American Journal of Cardiology

Volumn 101, Issue 11, 2008, Pages 1560-1566

  Maresta, Aleardo ^a   Varani, Elisabetta ^a   Balducelli, Marco ^a   Varbella, Ferdinando ^b   Lettieri, Corrado ^c   Uguccioni, Lucia ^d   Sangiorgio, Pietro ^e   Zoccai, Giuseppe Biondi ^f  

^a SANTA MARIA DELLE CROCI HOSPITAL   (Italy)

^b Degli Infermi Hospital   (Italy)

^c CARLO POMA HOSPITAL   (Italy)

^d SAN SALVATORE HOSPITAL   (Italy)

^e MAGGIORE HOSPITAL   (Italy)

^f UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; HEPARIN; INSULIN; ORAL ANTIDIABETIC AGENT; RAPAMYCIN; TIROFIBAN;

ACUTE CORONARY SYNDROME; AGED; ANGIOGRAPHY; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; CORONARY STENT; DIABETES MELLITUS; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG ELUTING STENT; DRUG SAFETY; FEMALE; HEART DISEASE; HEART MUSCLE REVASCULARIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; PATIENT SAFETY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESTENOSIS; TREATMENT OUTCOME;

AGED; COATED MATERIALS, BIOCOMPATIBLE; CORONARY ANGIOGRAPHY; CORONARY STENOSIS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; ITALY; MALE; METALS; MYOCARDIAL INFARCTION; MYOCARDIAL REVASCULARIZATION; PROSPECTIVE STUDIES; RISK FACTORS; SINGLE-BLIND METHOD; SIROLIMUS; STENTS; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 43549111358     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2008.01.040     Document Type: Article

References (24)

1. Stone K.E., Chiquette E., and Chilton R.J. Diabetic endovascular disease: role of coronary artery revascularization. Am J Cardiol 99 suppl (2007) 105B-112B
2. BARI Investigators. Seven-year outcome in the Bypass angioplasty Revascularization Investigation (BARI) by treatment and diatetic status. J Am Coll Cardiol 35 (2000) 1122-1129
3. King III S.B., Kosinski A.S., Guyton R.A., Lembo N.J., and Weintraub W.S. Eight-year mortality in the Emory Angioplasty versus Surgery Trial (EAST). J Am Coll Cardiol 35 (2000) 1116-1121
4. Abizaid A., Costa M.A., Centemero M., Abizaid A.S., Legrand V.M., Limet R.V., Schuler G., Mohr F.W., Lindeboom W., Sousa A.G., et al. Clinical and economic impact of diabetes mellitus on percutaneous and surgical treatment of multivessel coronary disease: insights from the Arterial Revascularization Therapy Study (ARTS) trial. Circulation 104 (2001) 533-538
5. SoS Investigators. Coronary artery bypass surgery versus percutaneous coronary intervention with stent implantation in patients with multivessel coronary artery disease (the Stent or Surgery trial): a randomised controlled trial. Lancet 360 (2001) 965-970
6. Rodriguez A., Bernardi V., Navia J., Baldi J., Grinfeld L., Martinez J., Vogel D., Grinfeld R., Delacasa A., Garrido M., et al. Argentine randomized study: coronary angioplasty with stenting versus coronary bypass surgery in patients with multiple-vessel disease (ERACI II): 30-day and one-year follow-up results. J Am Coll Cardiol 37 (2001) 51-58
7. Abizaid A., Kornowski R., Mintz G.S., Hong M.K., Abizaid A.S., Mehran R., Pichard A.D., Kent K.M., Satler L.F., Wu H., Popma J.J., and Leon M.B. The influence of diabetes mellitus on acute and late clinical outcomes following coronary stent implantation. J Am Coll Cardiol 32 (1998) 584-589
8. Wilson S.R., Vakili B.A., Sherman W., Sanborn T.A., and Brown D.L. Effect of diabetes on long-term mortality following contemporary percutaneous coronary intervention: analysis of 4,284 cases. Diabetes Care 27 (2004) 1137-1142
9. Sabatè M., Jimez-Quevedo P., Angiolillo D.J., Gòmez-Hospital J.A., Alfonso F., Hernàndez-Antolìn R., Goicolea J., Banuelos C., Escaned J., Moreno R., et al., DIABETES Investigators. Randomized comparison of sirolimus-eluting stent versus standard stent for percutaneous coronary revascularization in diabetic patients. The Diabetes and sirolimus-Eluting Stent (DIABETES) trial. Circulation 112 (2005) 2175-2183
10. Chan C., Zambahari R., Kaul U., Cohen S.A., Buchbinder M., and DECODE Investigators. Outcomes in diabetic patients with multivessel disease and long lesions: results from the DECODE study. Am J Cardiol 96 suppl 7A (2005) 31H
11. Moussa I., Leon M.B., Baim D.S., O'Neill W.W., Popma J.J., Buchbinder M., Midwall J., Simonton C.A., Keim E., Wang P., Kuntz R.E., and Moses J.W. Impact of sirolimus-eluting stents on outcome in diabetic patients. A SIRIUS (Sirolimus-coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo coronary artery lesions) substudy. Circulation 109 (2004) 2273-2278
12. Schenn A.J., Warzee F., and Legrand V.M. Drug-eluting stents: meta-analysis in diabetic patients. Eur Heart J 25 (2004) 2167-2168
13. Hermiller J.B., Raizner A., Cannon L., Gurbel P.A., Kutcher M.A., Wong S.C., Russell M.E., Ellis S.G., Mehran R., and Stone G.W. Outcomes with the polymer-based paclitaxel-eluting TAXUS stent in patients with diabetes mellitus: the TAXUS-IV trial. J Am Coll Cardiol 45 (2005) 1172-1179
14. Roiron C., Sanchez P., Bouzamondo A., Lechat P., and Montalescot G. Drug eluting stents: an updated meta-analysis of randomised controlled trials. Heart 92 (2006) 641-649
15. Stettler C., Allemann S., Egger M., Windecker S., Meier B., and Diem P. Efficacy of drug eluting stents in patients with and without diabetes mellitus: indirect comparison of controlled trials. Heart 92 (2006) 650-657
16. Lemos P.A., Serruys P.W., van Domburg R.T., Saia F., Arampatzis C.A., Hoye A., Degertekin M., Tanabe K., Daemen J., Liu T.K., et al. Unrestricted utilization of sirolimus-eluting stents compared with conventional bare stent implantation in the "real world": the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) registry. Circulation 109 (2004) 190-195
17. Ong A.T.L., Aoki J., van Mieghem C.A.G., Rodriguez Granillo G.A., Valgimigli M., Tsuchida K., Sonnenschein K., Regar E., van der Giessen W.J., de Jaegere P.P., et al. Comparison of short- (one month) and long- (twelve months) term outcomes of sirolimus- versus paclitaxel- eluting stents in 293 consecutive patients with diabetes mellitus (from the RESEARCH and T-SEARCH registries). Am J Cardiol 96 (2005) 358-362
18. Morice M.-C., Serruys P.W., Sousa E., Fajadet J., Ban Hayashi E., Perin M., Colombo A., Schuler G., Barragan P., Guagliumi G., Molnàar F., Falotico R., and RAVEL Study Group. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 346 (2002) 1773-1780
19. Cutlip D.E., Windecker S., Mehran R., Boam A., Cohen D.J., van Es G.-A., Steg G., Morel M.-A., Mauri L., Vranckx P., et al., Academic Research Consortium. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 115 (2007) 2344-2351
20. Mehran R., Dangas G., Abizaid A.S., Mintz G.S., Lansky A.J., Satler L.F., Pichard A.D., Kent K.M., Stone G.W., and Leon M.B. Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome. Circulation 100 (1999) 1872-1878
21. Marso S.P., Lincoff A.M., Ellis S.G., Bhatt D.L., Tanguay J.F., Kleiman N.S., Hammoud T., Booth J.E., Sapp S.K., and Topol E.J. Optimizing the percutaneous interventional outcomes for patients with diabetes mellitus: results of the EPISTENT (Evaluation of platelet IIb/IIIa inhibitor for stenting trial) diabetic substudy. Circulation 100 (1999) 2477-2484
22. Lincoff A.M. Important triad in cardiovascular medicine: diabetes, coronary intervention, and platelet glycoprotein IIb/IIIa receptor blockade. Circulation 107 (2003) 1556-1559
23. Corpus R.A., George P.B., House J.A., Dixon S.R., Ajluni S.C., Devlin W.H., Timmis G.C., Balasubramaniam M., and O'Neill W.W. Optimal glycemic control is associated with a lower rate of target vessel revascularization in treated type II diabetic patients undergoing elective percutaneous coronary intervention. J Am Coll Cardiol 43 (2004) 8-14
24. Pache J., Kastrati A., Mehilli J., Scuhlen H., Dotzer F., Hausleiter J., Fleckenstein M., Neumann F.J., Sattelberger U., Schmitt C., et al. Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO-2) trial. J Am Coll Cardiol 41 (2003) 1283-1288